Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Diabetes Technology & Therapeutics
|
October 21, 2014
Intramuscular risk at insulin injection sites--measurement of the distance from skin to muscle and rationale for shorter-length needles for subcutaneous insulin therapy
Laurence Hirsch, Karen Byron, Michael Gibney
The Diabetes Educator
|
August 17, 2012
Translating the research in insulin injection technique: implications for practice
Rita Saltiel-Berzin, Marjorie Cypress, Michael Gibney
Journal of Diabetes Science and Technology
|
April 28, 2012
Impact of a modified needle tip geometry on penetration force as well as acceptability, preference, and perceived pain in subjects with diabetes
Laurence Hirsch, Michael Gibney, Julie Berube, et al.
Diabetes Technology & Therapeutics
|
December 25, 2015
Reduced Silent Occlusions with a Novel Catheter Infusion Set (BD FlowSmart): Results from Two Open-Label Comparative Studies
Michael Gibney, Zhenyi Xue, Monica Swinney, et al.
Applied Nursing Research : ANR
|
January 30, 2007
Nurses' attitudes toward nursing research at a metropolitan medical center
Meg Smirnoff, Marjorie Ramirez, Linda Kooplimae, et al.
International Journal of Epidemiology
|
April 12, 2003
Distribution and determinants of sedentary lifestyles in the European Union
José J Varo, Miguel A Martínez-González, Jokin De Irala-Estévez, et al.
Circulation
|
April 16, 2016
High-Density Lipoprotein Proteomic Composition, and not Efflux Capacity, Reflects Differential Modulation of Reverse Cholesterol Transport by Saturated and Monounsaturated Fat Diets
Marcella O'Reilly, Eugene Dillon, Weili Guo, et al.
Journal of Medicinal Chemistry
|
December 16, 2011
Identification of 1-(3-(6,7-dimethoxyquinazolin-4-yloxy)phenyl)-3-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)urea hydrochloride (CEP-32496), a highly potent and orally efficacious inhibitor of V-RAF murine sarcoma viral oncogene homologue B1 (BRAF) V600E
Martin W Rowbottom, Raffaella Faraoni, Qi Chao, et al.
Journal of Medicinal Chemistry
|
July 16, 2020
Discovery and Characterization of Clinical Candidate LXE408 as a Kinetoplastid-Selective Proteasome Inhibitor for the Treatment of Leishmaniases
Advait Nagle, Agnes Biggart, Celine Be, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Diabetes Technology & Therapeutics
|
October 21, 2014
Intramuscular risk at insulin injection sites--measurement of the distance from skin to muscle and rationale for shorter-length needles for subcutaneous insulin therapy
Laurence Hirsch, Karen Byron, Michael Gibney
The Diabetes Educator
|
August 17, 2012
Translating the research in insulin injection technique: implications for practice
Rita Saltiel-Berzin, Marjorie Cypress, Michael Gibney
Journal of Diabetes Science and Technology
|
April 28, 2012
Impact of a modified needle tip geometry on penetration force as well as acceptability, preference, and perceived pain in subjects with diabetes
Laurence Hirsch, Michael Gibney, Julie Berube, et al.
Diabetes Technology & Therapeutics
|
December 25, 2015
Reduced Silent Occlusions with a Novel Catheter Infusion Set (BD FlowSmart): Results from Two Open-Label Comparative Studies
Michael Gibney, Zhenyi Xue, Monica Swinney, et al.
Applied Nursing Research : ANR
|
January 30, 2007
Nurses' attitudes toward nursing research at a metropolitan medical center
Meg Smirnoff, Marjorie Ramirez, Linda Kooplimae, et al.
International Journal of Epidemiology
|
April 12, 2003
Distribution and determinants of sedentary lifestyles in the European Union
José J Varo, Miguel A Martínez-González, Jokin De Irala-Estévez, et al.
Circulation
|
April 16, 2016
High-Density Lipoprotein Proteomic Composition, and not Efflux Capacity, Reflects Differential Modulation of Reverse Cholesterol Transport by Saturated and Monounsaturated Fat Diets
Marcella O'Reilly, Eugene Dillon, Weili Guo, et al.
Journal of Medicinal Chemistry
|
December 16, 2011
Identification of 1-(3-(6,7-dimethoxyquinazolin-4-yloxy)phenyl)-3-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)urea hydrochloride (CEP-32496), a highly potent and orally efficacious inhibitor of V-RAF murine sarcoma viral oncogene homologue B1 (BRAF) V600E
Martin W Rowbottom, Raffaella Faraoni, Qi Chao, et al.
Journal of Medicinal Chemistry
|
July 16, 2020
Discovery and Characterization of Clinical Candidate LXE408 as a Kinetoplastid-Selective Proteasome Inhibitor for the Treatment of Leishmaniases
Advait Nagle, Agnes Biggart, Celine Be, et al.
Page
of 1